Association between obsessive-compulsive disorder and dopamine transporter gene polymorphism

Psychiatry Investigation

Volumn 3, Issue 1, 2006, Pages 72-77

  Yoo, Sang Woo ^a   Kim, Se Joo ^b   Kim, Chan Hyung ^b  

^a YOO and KIM Mental Health Clinic   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Dopamine transporter; Obsessive compulsive disorder; Polymorphism

Indexed keywords

DNA; DOPAMINE TRANSPORTER; PROTEIN DAT1; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOPAMINERGIC TRANSMISSION; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROANATOMY; NEUROCHEMISTRY; OBSESSIVE COMPULSIVE DISORDER; PATHOPHYSIOLOGY; SEROTONIN RELEASE; STATISTICAL SIGNIFICANCE; VARIABLE NUMBER OF TANDEM REPEAT;

EID: 33645657587     PISSN: 17383684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Pauls DL, Alsobrook J, Goodman WK, Rasmussen SA, Leckman JF. A family study of obsessive-compulsive disorder. Am J Psychiatry 1995; 152:76-84.
2. Barr LC, Goodman WK, Price LH. The serotonin hypothesis of obsessive compulsive disorder. Int Clin Psychopharmacol 1993; 8 (Suppl) 2:79-82.
3. Stein DJ. The neurobiology of obsessive-compulsive disorder. Neuroscientist 1996; 2:300-305.
4. Goodman WK, McDougle CJ, Price LH, Riddle MA, Pauls DL, Leckman JF. Beyond the serotonin hypothesis: a role for dopamine in some forms of obsessive compulsive disorder? J Clin Psychiatry 1990; 51 (Suppl):36-43;55-58.
5. Agid O, Lerer B. Risperidone augmentation of paroxetine in a case of severe, treatment-refractory obsessive-compulsive disorder without comorbid psychopathology. J Clin Psychiatry 1999; 60:55-56.
6. Baker RW, Chengappa KN, Baird JW, Steingard S, Christ MA, Schooler NR. Emergence of obsessive compulsive symptoms during treatment with clozapine. J Clin Psychiatry 1992; 53:439-442.
7. Giros B, Caron MG. Molecular characterization of the dopamine transporter. Trends Pharmacol Sci 1993; 14:43-49.
8. Frisch A, Michaelovsky E, Rockah R, Amir I, Hermesh H, Laor N, Fuchs C, Zohar J, Lerer B, Buniak SF, Landa S, Poyurovsky M, Shapira B, Weizman R. Association between obsessive-compulsive disorder and polymorphisms of genes encoding components of the serotonergic and dopaminergic pathways. Eur Neuropsychopharmacol 2000; 10:205-209.
9. Hemmings SMJ, Kinnear CJ, Niehaus DJ, Moolman-Smook JC, Lochner C, Knowles JA, Corfield VA, Stein DJ. Investigating the role of dopaminergic and serotonergic candidate genes in obsessive-compulsive disorder. Eur Neuropsychopharmacol 2003; 13:93-98.
10. th ed. Washington DC. American Psychiatric Press, 1994.
11. Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, Heninger GR, Charney DS. The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry 1989; 46:1006-1011.
12. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967; 6:278-296.
13. Sano A, Kondoh K, Kakimoto Y, Kondo I. A 40-nucleotide repeat polymorphism in the human dopamine transporter gene. Hum Genet 1993; 91:405-406.
14. Mill J, Asherson P, Browes C, D'Souza U, Craig I. Expression of the dopamine transporter gene is regulated by the 3′ UTR VNTR: Evidence from brain and lymphocytes using quantitative RT-PCR. Am J Med Genet 2002; 114:975-979.
15. Fuke S, Suo S, Takahashi N, Koike H, Sasagawa N, Ishiura S. The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression. Pharmacogenomics J 2001; 1:152-156.
16. Vandenbergh DJ, Persico AM, Hawkins AL, Griffin CA, Li X, Jabs EW, Uhl GR. Human dopamine transporter gene (DATl) maps to chromosome 5p15.3 and displays a VNTR. Genomics 1992; 14:1104-1106.
17. Miller GM. Madras BK. Polymorphisms in the 3'-untranslated region of human and monkey dopamine transporter genes affect reporter gene expression. Mol Psychiatry 2002; 7:44-55.
18. Souery D, Rivelli SK, Mendlewicz J. Molecular genetic and family studies in affective disorders: state of the art. J Affect Disord 2001; 62:45-55.
19. Heinz A, Goldman D, Jones DW, Palmour R, Hommer D, Gorey JG, Lee KS, Linnoila M, Weinberger DR. Genotype influences in vivo dopamine transporter availability in human striatum. Neuropsychopharmacology 2000; 22:133-139.
20. Martinez D, Gelernter J, Abi-Dargham A, van Dyck CH, Kegeles L, Innis RB, Lamelle M. The variable number of tandem repeats polymorphism of the dopamine transporter gene is not associated with significant change in dopamine transporter phenotype in humans. Neuropsychopharmacology 2001; 24:553-560.
21. Jonsson EG, Nothen MM, Gustavsson JP, Neidt H, Bunzel R, Propping P, Sedvall GC. Polymorphisms in the dopamine, serotonin, and norepinephrine transporter genes and their relationships to monoamine metabolite concentrations in CSF of healthy volunteers. Psychiatry Res 1998; 79:1-9.
22. Kang AM, Palmatier MA, Kidd KK. Global variation of a 40-bp VNTR in the 3'-untranslated region of the dopamine transporter gene (SLC6A3) Biol Psychiatry 1999; 46:151-60.
23. Shin DW, Non KS, Oh KS, Lee MS. Association between attention deficit hyperactivity disorder and dopamine transporter gene (DAT1) polymorphism in Korea. J Korean Neuropsychiatr Assoc 2002; 41:612-618.
24. Kim JW, Kim BN, Cho SC. The dopamine transporter gene and the impulsivity phenotype in attention deficit hyperactivity disorder: A case-control association study in a Korean sample. J Psychiatr Res 2005 (in press)
25. Choi YJ, Bang SK, Kim JJ, Toh KY, Paik IH. Association of alcohol dependence with the dopamine transporter gene polymorphism. J Korean Neuropsychiatr Assoc 1999; 38:826-833.
26. Kim YS, Leventhal BL, Kim SJ, Kim BN, Cheon KA, Yoo HJ, Kim SJ, Badner J, Cook EH. Family-based association study of DAT1 and DRD4 polymorphism in Korean children with ADHD. Neurosci Lett 2005; 390:176-181.
27. Oh KS, Yoon HK, Lee MS. Polymorphism of dopamine transporter gene (DAT1) in Korean social phobia patients: preliminary study. J Korean Soc Biol Psychiatry 2004; 11: 165-172.
28. Kim DK, Kim EJ, Lim SW, Kim H. Association between the genetic polymorphisms of the biogenic amine transporters and the antidepressant responsiveness in Korean depressed patients. Korean J Psychopharmacol 2003; 14: 274-283.